[Particle radiotherapy for malignant gliomas].

Abstract

Particle radiations using protons or carbons, and boron neutron capture therapy are emerging as a therapeutic modality for malignant gliomas. Some non-randomized prospective studies found favorable results; however, the advantageous method of advantage of conformal radiation using protons or carbon ions and tumor cell-selective radiation using boron neutron capture therapy have not been confirmed. In a recent clinical trial involving 20 newly diagnosed glioblastomas at the Proton Medical Research Center at Tsukuba, the median overall survival time and the 1- and 2-year survival rates were 21.6 months, 71.1% and 45.3%, respectively. In the clinical trial of boron neutron capture therapy of 15 newly diagnosed glioblastomas at Tsukuba, the median overall survival time and the 1- and 2-year survival rates were 25.7 month, 80.0% and 53.3%, respectively. The rationale, history, and clinical results of particle radiotherapy for glioblastoma were also discussed.

• Authors: Tetsuya Yamamoto, Koji Tsuboi
• Journal: Brain and nerve = Shinkei kenkyu no shinpo (Brain Nerve) Vol. 61 Issue 7 Pg. 855-66 (Jul 2009) ISSN: 1881-6096 [Print] Japan
• PMID: 19618864 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)

Chemical References

• Carbon Radioisotopes

Topics

• Boron Neutron Capture Therapy
• Brain Neoplasms (radiotherapy)
• Carbon Radioisotopes (therapeutic use)
• Clinical Trials as Topic
• Glioma (radiotherapy)
• Humans
• Neutron Capture Therapy (instrumentation, trends)
• Proton Therapy
• Treatment Outcome